Abstract Details

Title Reversible Effects of Daclizumab HYP on Lymphocyte Counts in RRMS Patients: Data from the SELECT Trilogy Studies

Topic Multiple Sclerosis

Presentation(s) (-)

Poster/Presentation
Number 281

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Sami Fam PRESENTER	Sami Fam has received personal compensation for serving as an employee of Alexion Pharmaceuticals. Sami Fam has or had stock in Astra Zeneca.
	No disclosure on file
Devangi S. Mehta, PhD (Biogen)	No disclosure on file
Katherine A. Riester, MPH (Biogen)	No disclosure on file
James Sheridan, PhD (Abbott Labs)	No disclosure on file
Peter McCroskery	No disclosure on file
Jacob S. Elkins, MD	No disclosure on file
Lakshmi S. Amaravadi, PhD (Sr. Director, Translational Medicine)	No disclosure on file

��ɫ����